US Patent 7687242 KID31 and antibodies that bind thereto
Patent 7687242 was granted and assigned to Raven Biotechnologies on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+306 characters)
Article
Patent abstract
The invention provides the identification and characterization of disease and cancer-associated antigen, KID31. The invention also provides a family of monoclonal antibodies that bind to antigen KID31, methods of diagnosing and treating various human cancers and diseases that express KID31.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Deryk T. Loo0
Jennie P. Mather0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07687242 KID31 and antibodies that bind thereto US Patent 7687242 KID31 and antibodies that bind thereto
Infobox
Patent Number
07687242
Patent Number
7687242
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07687242 KID31 and antibodies that bind thereto
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07687242
Date of patent
March 30, 2010
Patent application number
11331717
Date Filed
January 12, 2006
Patent primary examiner
Find more entities like US Patent 7687242 KID31 and antibodies that bind thereto
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
